Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Center for Autisme, Denmark Norway: Bo Nils og Seim Family Settlement The Robert Luff Foundation, United Kingdom Eric Birger Christensen Fond, Denmark Norsk Proteinintolerance, Norway |
---|---|
Information provided by: | Center for Autisme, Denmark |
ClinicalTrials.gov Identifier: | NCT00614198 |
A growing body of research indicates that intervention, excluding foods containing the proteins, gluten and casein, from the diet of children diagnosed with an autism spectrum disorder may have a positive effect on behaviour and cognition.
In this single-blinded, randomised, matched-pair trial, we introduce a gluten- and casein-free diet to a group of pre-pubescent children diagnosed with an autism spectrum disorder who also present with an abnormal urinary profile. Following random allocation to a diet or non- diet group, the intervention group will follow the diet for eight months. The non-diet control group will at the same time continue with a normal diet.
At eight months an interim evaluation using standardised autism evaluation methods is used to ascertain whether predetermined thresholds for improvement in any of the assessment measures are met or surpassed by the diet group, compared with initial baseline measures.
If such thresholds are surpassed, the non-diet control group will also start on dietary intervention, with both groups following the diet for a further eight months. In the event such thresholds are not achieved, the intervention group will remain on diet for an additional four months, at which time a secondary interim analysis will be conducted.
After eight plus four months, if the threshold for improvement has been surpassed by the intervention group, the control group will then enter on dietary intervention, and all participants will follow the diet for another twelve months. In the event that no significant improvement has been found in the intervention group at eight plus four months compared to baseline measures, the study will be halted, and both groups will revert back to a normal diet.
Condition | Intervention | Phase |
---|---|---|
Autism |
Dietary Supplement: Gluten- and casein-free diet |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Investigator), Parallel Assignment, Safety/Efficacy Study |
Official Title: | The ScanBrit Randomised Controlled Study of Gluten- and Casein-Free Dietary Intervention for Children With Autism Spectrum Disorders |
Enrollment: | 80 |
Study Start Date: | April 2006 |
Estimated Study Completion Date: | October 2008 |
Estimated Primary Completion Date: | October 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Experimental
Submitted to dietary intervention
|
Dietary Supplement: Gluten- and casein-free diet
Gluten- and casein-free diet
|
B: No Intervention
Control group
|
Ages Eligible for Study: | 4 Years to 11 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Center for Autisme ( Director Demetrious Haracopos ) |
Study ID Numbers: | KA 0503g |
Study First Received: | January 31, 2008 |
Last Updated: | January 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00614198 |
Health Authority: | Denmark: The Danish National Committee on Biomedical Research Ethics |
autism diet gluten casein |
intervention peptide randomised controlled |
Developmental Disabilities Child Development Disorders, Pervasive Caseins |
Mental Disorders Autistic Disorder Mental Disorders Diagnosed in Childhood |
Molecular Mechanisms of Pharmacological Action Chelating Agents Pharmacologic Actions |